Clinical Trial Details
— Status: Active, not recruiting
Administrative data
NCT number |
NCT05694286 |
Other study ID # |
852212 |
Secondary ID |
|
Status |
Active, not recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
January 6, 2023 |
Est. completion date |
February 29, 2024 |
Study information
Verified date |
January 2024 |
Source |
University of Pennsylvania |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
The goal of this clinical trial is to measure the facial volumetric changes over time in
patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the
infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC
filler and asked to return for 3D photography at 2 weeks, 1 month, and 3 months
post-injection.
Description:
Undereye or infraorbital hollowing is a result of a loss of volume causing shadowing and
darkness of the infraorbital region often interpreted as a tired, stressed, and aged
appearance.
The goal of this clinical trial is to measure the facial volumetric changes over time in
patients injected with hyaluronic acid dermal filler (Juvéderm Volbella XC) in the
infraorbital (under eye) region. Participants will be injected with Juvéderm Volbella XC
filler and asked to return for 3D photography and to complete a validated patient
satisfaction questionnaire at 2 weeks, 1 month, and 3 months post-injection. 3D
photogrammetry technology allows for high level feature enhancement and microscopic
anatomical evaluation that was not previously possible and can be used to make volumetric
measurements at injection sites to evaluating minimally invasive injection efficacy.